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Abstract: Hairpin pyrrole-imidazole (Py-Im) polyamides are a class of cell-permeable DNA-binding small
molecules that can disrupt transcription factor-DNA binding and regulate endogenous gene expression.
The covalent linkage of antiparallel Py-Im ring pairs with an γ-amino acid turn unit affords the classical
hairpin Py-Im polyamide structure. Closing the hairpin with a second turn unit yields a cyclic polyamide, a
lesser-studied architecture mainly attributable to synthetic inaccessibility. We have applied our methodology
for solution-phase polyamide synthesis to cyclic polyamides with an improved high-yield cyclization step.
Cyclic 8-ring Py-Im polyamides 1-3 target the DNA sequence 5′-WGWWCW-3′, which corresponds to the
androgen response element (ARE) bound by the androgen receptor transcription factor to modulate gene
expression. We find that cyclic Py-Im polyamides 1-3 bind DNA with exceptionally high affinities and regulate
the expression of AR target genes in cell culture studies, from which we infer that the cycle is cell permeable.
Introduction
Modulating the expression of eukaryotic gene networks by
small molecules is a challenge at the frontier of chemical
biology. Pyrrole-imidazole polyamides are a class of cell-
permeable small molecules that bind to the minor groove of
DNA in a sequence-specific manner.1,2 Side-by-side stacked
N-methylpyrrole (Py) and N-methylimidazole (Im) carboxamides
(Im/Py pairs) distinguish G ·C from C ·G base pairs, whereas
Py/Py pairs specify for both T ·A and A ·T.3 Py-Im hairpin
polyamides have been programmed for a broad repertoire of
DNA sequences with affinities similar to those of endogenous
transcription factors.4 They are cell permeable and influence
gene transcription by disrupting protein-DNA interfaces.2,5,6
Hairpin polyamide interference of DNA binding by transcription
factors such as HIF-1R,7 androgen receptor (AR),8 and AP-19
has been described in recent years, yielding a new approach
toward gene control by small molecules.
In parallel with our gene regulation studies, a significant effort
has been devoted to maximizing the biological potency of
hairpin Py-Im polyamides through structural modifications. In
particular, we have recently demonstrated that hairpin polya-
mides bearing the (R)--amino-γ-turn, such as polyamide 4,
possess favorable binding affinities to DNA and are useful in
gene regulation studies (Figure 1).5g A significant effort exists
in our laboratory to regulate aberrant AR-activated gene
(1) Dervan, P. B. Bioorg. Med. Chem. 2001, 9, 2215–2235.
(2) Dervan, P. B.; Edelson, B. S. Curr. Opin. Struct. Biol. 2003, 13, 284–
299.
(3) (a) Trauger, J. W.; Baird, E. E.; Dervan, P. B. Nature 1996, 382, 559–
561. (b) White, S.; Szewczyk, J. W.; Turner, J. M.; Baird, E. E.;
Dervan, P. B. Nature 1998, 391, 468–470. (c) Kielkopf, C. L.; Baird,
E. E.; Dervan, P. B.; Rees, D. C. Nat. Struct. Biol. 1998, 5, 104–109.
(d) Kielkopf, C. L.; White, S.; Szewczyk, J. W.; Turner, J. M.; Baird,
E. E.; Dervan, P. B.; Rees, D. C. Science 1998, 282, 111–115.
(4) Hsu, C. F.; Phillips, J. W.; Trauger, J. W.; Farkas, M. E.; Belitsky,
J. M.; Heckel, A.; Olenyuk, B. Z.; Puckett, J. W.; Wang, C. C. C.;
Dervan, P. B. Tetrahedron 2007, 63, 6146–6151.
Figure 1. Structures of cyclic and hairpin polyamides 1-5 targeted to the
DNA sequence 5′-WGWWCW-3′ and their ball-and-stick models. Black
and white circles represent N-methylimidazole and N-methylpyrrole units,
respectively, IPA denotes the terminal isophthalic acid substituent, and white
half-diamond with + sign represents the triamine linker unit.
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expression in prostate cancer.8To further optimize lead oligomer
4, it would seem reasonable that closing the hairpin with an
identical linker, yielding a cyclic structure 1, would further
enhance DNA affinity (Figure 1). Previous syntheses of cyclic
polyamides using solid-phase protocols are characterized by low
reaction yields due to inefficient macrocyclization.10 We report
here the solution-phase synthesis of cyclic polyamides 1-3 with
an improved high-yield cyclization step. In addition, we
examined the DNA binding properties of these compounds by
thermal duplex DNA melting and performed preliminary studies
of their in Vitro ADMET properties. Cyclic Py-Im polyamides
1-3 were shown to regulate endogenous gene expression in
cell culture experiments.
Results and Discussion
Solution-Phase Synthesis of Cyclic Polyamides. Due to the
symmetrical nature of cyclic polyamides 1-3 and their sequence
similarity to previously described hairpin polyamide 4,11 PyPyPy
trimer 6 and Im-turn dimer 7 provide all the necessary atoms
to synthesize 1-3. The preparation of advanced intermediates
6 and 7 has been detailed in the preceding paper (DOI 10.1021/
ja901307m)11 from readily available building blocks.12 The
cornerstone of our synthesis strategy capitalizes on the disparate
physical properties of starting materials versus products, which
permit purification of most intermediates to be achieved by
combinations of precipitation, trituration, and crystallization. In
addition, in situ deprotection of advanced pentafluorophenyl
ester polyamide 14 at high dilution leads to macrocyclization
in high yield, affording cyclic polyamide 15.
The synthesis of tetramer-turn 9 begins with Im-turn dimer
7 (Scheme 1). Saponification of 7 with aqueous KOH in
methanol at 37 °C, followed by neutralization, precipitation,
and Et2O trituration, yields Im-turn acid 8 in 95% yield. Amide
coupling of 8 with pyrrole trimer 6 provides pentamer 9 in 96%
yield. The utilization of a small excess of 6 relative to 8 drives
the reaction to completion, and residual 6 is readily separated
from 9 following precipitation in water and aqueous washing
of residual solid 9. With all atoms in place for the target cyclic
polyamide 1, compound 9 was elaborated to amine salt 10 (99%
yield) by reaction with HCl in 1,4-dioxane. Carboxylic acid 11
was generated by saponification of 9 with NaOH in 1,4-dioxane
in 95% yield.
Assembly of the acyclic advanced intermediate 12 was
achieved by PyBOP-mediated coupling of intermediates 10 and
11 in 94% yield (Scheme 2). A small excess of amine salt 10
was utilized to drive the reaction to completion. Saponification
of ester 12 proceeded smoothly with aqueous NaOH in 1,4-
dioxane, yielding 13 in 93% yield. Activation of acid 13 as the
pentafluorophenol ester 14 provided the necessary functionality
to afford macrocyclization following removal of the terminal
tert-butyl carbamate (Boc) protecting group. In our hands, we
found that the pentafluorophenol ester sufficiently activated the
terminal acid for amide coupling while avoiding undesired
oligomerization and/or decomposition processes that are con-
ceivable with more reactive functionalities, such as acid
chlorides. Premature initiation of the macrocyclization reaction
was tempered by keeping the terminal amine protonated until
it was transferred into a dilute solution of acetonitrile. Addition
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Scheme 1. Preparation of 10 and 11a
a Reagents and conditions: (i) M KOH(aq), MeOH, 37 °C, 2 h, 95%;
(ii) 8, PyBOP, DMF, DIEA, 6, 23 °C, 4 h, 96%; (iii) 4.0 M HCl in 1,4-
dioxane, 23 °C, 2 h, 99%; (iv) M NaOH(aq), 1,4-dioxane, 42 °C, 3 h, 95%.
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of an amine base (DIEA) then generated the free terminal amine,
which could then undergo macrocyclization in dilute solvent
conditions to deliver 15, which was directly deprotected
following purification. The benzyl carbamate protecting groups
were cleaved by treatment with superacid conditions (trifluo-
romethylsulfonic acid-trifluoroacetic acid) to provide 1 in 68%
yield over three steps. Controlled acetylation of 1 by reaction
with substoichiometric quantities of Ac2O in NMP/DIEA
provided a statistical population of 1 (18%), 2 (22%), and 3
(40%) that were easily separable by preparative HPLC. Acety-
lated hairpin 5 was prepared using excess Ac2O/pyridine in 95%
yield from previously reported amine hairpin 4.11
Thermal Stabilization of DNA Duplexes by Polyamides.
Quantitative DNase I footprint titrations have historically been
utilized to measure polyamide-DNA binding affinities and
specificities.13 However, this method is limited to measuring
Ka values e2 × 1010 M-1, which invalidates this technique for
quantifying the exceptionally high DNA-binding affinities of
cycles 1-3.14 The magnitude of DNA thermal stabilization
(∆Tm) of DNA-polyamide complexes has been utilized to rank
order polyamides with high DNA binding affinities.5g,15 Ac-
cordingly, we have employed melting temperature analysis
(∆Tm) for dissecting differences in DNA-binding affinities of
hairpin versus cyclic polyamides. Spectroscopic analyses were
performed on a 14-mer duplex DNA mimicking the androgen
response element (ARE) DNA sequence, 5′-TTGCTGTTCT-
GCAA-3′ DNA duplex, which contains one polyamide binding
site. As shown in Table 1, polyamides 1-5 provided an increase
in the duplex DNA melting temperature relative to the individual
DNA duplex, thereby confirming polyamide-DNA binding.
Chiral hairpin 4 led to an increased melting temperature, ∆Tm
) 18.4 °C, whereas cyclic polyamide 1 yielded a higher ∆Tm
value of 23.6 °C. Cyclic polyamides 1-3 reveal stronger
stabilizations than parent hairpin analogues 4 and 5. Acylation
of the -amino turns was shown to decrease the thermal
stabilization values in both hairpin and cyclic motifs, presumably
due to the loss of the electrostatic benefit of the cation-protonated
amine on the turn unit.
Biological Assay for Cell Permeability. Hairpin polyamides
have been shown to modulate endogenous gene expression in
living cells by disrupting transcription factor-DNA binding in
gene promoters.2,7-9 Recently, hairpin polyamide 4 was shown
to inhibit androgen receptor-mediated expression of prostate-
specific antigen (PSA) in LNCaP cells by targeting the DNA
(13) Trauger, J. W.; Dervan, P. B. Methods Enzymol. 2001, 340, 450–
466.
(14) For examples of polyamides with Ka values >2 × 1010 M-1 and a
discussion of the limitations of quantitative DNase I footprint titrations,
please refer to ref 5g. A polyamide analogous to 4, ImPyPyPy-
(R)-H2Nγ-ImPyPyPy--Dp, was found to have Ka > 2 × 1010 M-1.5g
Additionally, previous studies with cyclic polyamide cyclo-(-ImPy-
PyPy-(R)R-H2Nγ-ImPyPyPy-γ-) found Ka values far exceeding 2 ×
1010 M-1 by DNase I footprint titrations.10c,d Cyclic polyamide 1
possesses dual -amino functionalities, a modification that yields even
greater DNA binding affinities compared with R-amino and unsub-
stituted γ-turns for hairpin polyamides of sequence ImPyPyPy-γ-
ImPyPyPy.5g The DNA binding affinity of 1 most likely supersedes
that of predecessor cyclo-(-ImPyPyPy-(R)R-H2Nγ-ImPyPyPy-γ-).
(15) (a) Pilch, D. S.; Poklar, N.; Gelfand, C. A.; Law, S. M.; Breslauer,
K. J.; Baird, E. E.; Dervan, P. B. Proc. Natl. Acad. Sci. U.S.A. 1996,
93, 8306–8311. (b) Pilch, D. S.; Poklar, N.; Baird, E. E.; Dervan,
P. B.; Breslauer, K. J. Biochemistry 1999, 38, 2143–2151.
Scheme 2. Preparation of 1, 2, and 3a
a Reagents and conditions: (i) PyBOP, DMF, DIEA, 23°C, 2 h, 94%;
(ii) NaOH(aq), 1,4-dioxane, 40°C, 4 h, 93%; (iii) CH2Cl2, DCC, pentafluo-
rophenol, DMAP, 23°C, 12 h, 80%; (iv) a) TFA, CH2Cl2, 23°C, concentrate;
b) DMF, acetonitrile, DIEA, 0-23°C, 3 days; (v) CF3SO3H, CF3CO2H,
23°C, 5 min, 68% over 3 steps; (vi) NMP, DIEA, Ac2O, 23°C, 18% of 1
(recovered), 22% of 2, 40% of 3.
Table 1. Tm Values for Polyamides for 1-5a
a All values reported are derived from at least three melting
temperature experiments with standard deviations indicated in
parentheses. ∆Tm values are given as Tm(DNA/polyamide) - Tm(DNA). The
propagated error in ∆Tm measurements is the square root of the sum of
the square of the standard deviations for the Tm values.
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sequence 5′-AGAACA-3′ found in the ARE.5g We utilized this
cell culture transcription assay to investigate the biological
activity of cyclic polyamides 1-3 in comparison to hairpin
polyamides 4 and 5. Since small structural changes to polya-
mides have been shown to correlate with differences in cellular
uptake properties,5 it was not obvious whether cyclic polyamides
1-3 would permeate cell membranes and exhibit biological
activity comparable to that of hairpin polyamides 4 and 5.
Quantitative real-time RT-PCR analysis of DHT-induced PSA
expression revealed that cyclic polyamides 1-3 all decreased
PSA mRNA levels in LNCaP cells, with cycle 1 exhibiting
activity comparable to that of acetylated hairpin polyamide 5
(Figure 2). On the basis of these results, we can infer that this
class of cyclic Py-Im polyamides are cell permeable and can
regulate endogenous gene expression in cell culture.
ADMET Studies of Polyamides 1 and 5. Due to the promising
cell culture results obtained with cyclic polyamide 1 and hairpin
polyamide 5 against PSA gene expression, we contracted
preclinical in Vitro absorption, distribution, metabolism, excre-
tion, and toxicity (ADMET)17 studies for both compounds.18
Results from this study are summarized below, and additional
detail can be found in the Supporting Information. Polyamides
1 and 5 were both found to exhibit low Caco-2 permeability,
suggesting that neither compound may be orally available. Both
1 and 5 were found to be almost exclusively protein bound in
plasma, with half-lives greater than 2 h. A recent positron
emission tomography (PET)-based biodistribution study of a
related hairpin polyamide in mice revealed high levels of liver
occupancy following tail vein dosage.19 On the basis of this
result, we investigated the liver stability of candidate polyamides
1 and 5. Microsomal intrinsic clearance studies found half-lives
greater than 3 h for 1 and 5 in both human and rat liver
microsomes, and no significant inhibition was measured against
any cytochrome P450 isoform examined (Cyp1A2/CEC, Cyp2C8/
DBF, Cyp2C9/DBF, Cyp2C19/DBF, Cyp2D6/AMMC, Cyp3A4/
BFC, Cyp3A4/DBF). Furthermore, no obvious toxicity (IC50 >
100 µM) was observed in the human hepatocellular carcinoma
cell line HepG2. In addition, standard hERG FastPatch assays
of cardiac toxicity found that both polyamides (1 and 5) were
devoid of unwanted inhibition (IC50 > 100 µM).
Conclusion
We describe a solution-phase synthesis methodology for
preparing cyclic Py-Im polyamides, highlighted by an efficient
macrocyclization between the alkyl linker amine and a pen-
tafluorophenol ester-activated amino acid. The three cyclic Py-
Im polyamides possessed high DNA-binding affinities and were
capable of accessing the nucleus in cell culture, as judged by
their ability to downregulate AR-activated PSA expression in
cell culture. Preclinical ADMET analysis of cyclic polyamide
1 and hairpin polyamide 5 revealed favorable drug-like proper-
ties such as high liver stability and low toxicity. Ongoing work
is focused on characterizing the precise molecular interactions
between cyclic polyamides and their cognate DNA sequences
by high-resolution crystallographic studies.
Experimental Section
General. Chemicals and solvents were purchased from Sigma-
Aldrich and were used without further purification. (R)-3,4-Cbz-
(16) Shaffer, P. L.; Jivan, A.; Dollins, D. E.; Claessens, F.; Gewirth, D. T.
Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 4758–4763.
(17) For a review of pharmacokinetics in drug discovery, see: Ruiz-Garcia,
A.; Bermejo, M.; Moss, A.; Casabo, V. G. J. Pharm. Sci. 2008, 97,
654–690.
(18) Apredica, 313 Pleasant St., Watertown, MA 02472 (http://www.
apredica.com/).
(19) Harki, D. A.; Satyamurthy, N.; Stout, D. B.; Phelps, M. E.; Dervan,
P. B. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 13039–13044.
Figure 2. Targeting the ARE with DNA-binding polyamides. (a) X-ray crystal structure of androgen receptor homodimer DNA-binding domain bound to
the sequence 5′-CTGTTCTTGATGTTCTGG-3′ (PDB 1r4i).16 (b) Map of the PSA-ARE site (top) and schematic representation of a cyclic polyamide
targeting the PSA-ARE site 5′-AGAACA-3′. (c) Inhibition of induced PSA mRNA expression in LNCaP cells by cyclic Py-Im polyamides 1-3 and hairpin
polyamides 4 and 5 (dosed at 0.3, 3, and 30 µM) by real-time quantitative PCR. The results were normalized to a DHT-induced, untreated control (control
) 1), and the error bars represent the standard error of the mean of a single experiment performed in biological triplicate. The entire experiment was
reproduced four times, with similar results. NI ) noninduced, I ) induced, DHT ) dihydrotestosterone.
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Dbu(Boc)-OH was purchased from Senn Chemicals AG (code
number 44159). All DNA oligomers were purchased HPLC purified
from Integrated DNA Technologies. Water (18 MΩ) was purified
using a Millipore Milli-Q purification system. Centrifugation was
performed in a Beckman Coulter benchtop centrifuge (Allegra 21R)
equipped with a Beckman swing-out rotor (model S4180). Analyti-
cal HPLC analysis was conducted on a Beckman Gold instrument
equipped with a Phenomenex Gemini analytical column (250 ×
4.6 mm, 5 µm) and a diode array detector, and the mobile phase
consisted of a gradient of acetonitrile (MeCN) in 0.1% (v/v) aqueous
CF3CO2H. Preparative HPLC was performed on an Agilent 1200
system equipped with a solvent degasser, a diode array detector,
and a Phenomenex Gemini column (250 × 21.2 mm, 5 µm). A
gradient of MeCN in 0.1% (v/v) aqueous CF3CO2H was utilized
as the mobile phase. UV-vis measurements were made on a
Hewlett-Packard diode array spectrophotometer (model 8452 A),
and polyamide concentrations were measured in 0.1% (v/v) aqueous
CF3CO2H using an extinction coefficient of 69 200 M-1 cm-1 at
λmax near 310 nm. NMR spectroscopy was performed on a Varian
instrument operating at 499.8 (for 1H) or 125.7 MHz (for 13C) at
ambient temperature. All NMR analyses were performed in DMSO-
d6, and chemical shifts are reported in parts per million relative to
the internal solvent peak referenced to 2.49 (for 1H) or 39.5 (for
13C). High-resolution mass spectrometry (HRMS) was recorded in
positive-ion mode by fast-atom bombardment (FAB+) on a JEOL
JMS-600H instrument or by electrospray ionization (ESI+) on a
Waters Acquity UPLC-LCT Premiere XE TOF-MS system.
UV Absorption Spectrophotometry. Melting temperature analy-
sis was performed on a Varian Cary 100 spectrophotometer equip-
ped with a thermo-controlled cell holder possessing a cell path
length of 1 cm. A degassed aqueous solution of 10 mM sodium
cacodylate, 10 mM KCl, 10 mM MgCl2, and 5 mM CaCl2 at pH
7.0 was used as analysis buffer. DNA duplexes and polyamides
were mixed in 1:1 stoichiometry to a final concentration of 2 µM
for each experiment. Prior to analysis, samples were heated to 90
°C and cooled to a starting temperature of 23 °C with a heating
rate of 5 °C/min for each ramp. Denaturation profiles were recorded
at λ ) 260 nm from 23 to 90 °C with a heating rate of 0.5 °C/min.
The reported melting temperatures were defined as the maximum
of the first derivative of the denaturation profile.
Measurement of Androgen-Induced PSA mRNA. Experiments
were performed as described previously8 with the following
modifications: (1) all compounds and controls were prepared in
neat DMSO and then diluted with media to a final concentration
of 0.1% DMSO, and (2) mRNA was isolated with the RNEasy 96
kit (Qiagen, Valencia, CA).
BocHN-(R)-CbzHNγ-Im-CO2H (8). A solution of BocHN-
(R)-CbzHNγ-Im-CO2Et 7 (450 mg, 0.894 mmol) dissolved in MeOH
(1.0 mL) and aqueous KOH (1 N, 2.0 mL, 2.0 mmol) was stirred
at 37 °C for 2 h. The reaction mixture was added to a cooled (ice
bath) solution of distilled H2O (10 mL) preacidified with aqueous
HCl (1 N, 2.0 mL, 2.0 mmol), yielding a precipitate that was
isolated by centrifugation (∼4500 rpm). The residual solid was
again suspended in distilled H2O (10 mL) and collected by
centrifugation. The resultant solid, which contained a small amount
of residual H2O, was frozen and lyophilized to dryness and then
suspended in excess anhydrous Et2O and filtered, and the filter cake
washed with copious amounts of anhydrous Et2O. Drying of the
brown solid in Vacuo yielded saponified dimer 8 (404 mg, 95%).
1H NMR: δ 10.46 (s, 1H), 7.47 (s, 1H), 7.31-7.26 (m, 5H), 7.02
(d, J ) 8.3 Hz, 1H), 6.79 (t, J ) 5.4 Hz, 1H), 4.97 (s, 2H), 3.92
(m, 1H), 3.88 (s, 3H), 3.60 (s, 1H), 3.01 (m, 2H), 2.41 (m, 2H),
1.35 (s, 9H). 13C NMR: δ 167.6, 160.0, 155.8, 155.4, 137.11,
137.09, 131.6, 128.2, 127.66, 127.55, 114.6, 77.7, 65.1, 48.7, 43.5,
38.0, 35.4, 28.2. HRMS (FAB+): calcd for C22H30N5O7 [M + H]+,
476.2145; found, 476.2130.
BocHN-(R)-CbzHNγ-ImPyPyPy-CO2Me (9). A solution of Boc-
HN-(R)-CbzHNγ-Im-CO2H 8 (300 mg, 0.631 mmol) and PyBOP (345
mg, 0.663 mmol) in DMF (3.2 mL) and DIEA (330 µL, 1.9 mmol)
was stirred at 23 °C for 10 min. The solution was then treated with
solid (powdered) HCl ·H2N-PyPyPy-CO2Me 6 (288 mg, 0.663
mmol) and stirred at 23 °C for 4 h. The solution was then added to
distilled H2O (10 mL) preacidified with aqueous HCl (1 N, 2 mL,
2 mmol), yielding a precipitate that was isolated by centrifugation
(∼4500 rpm). The residual solid was again suspended in distilled
H2O (10 mL) and collected by centrifugation (repeated 3×). The
resultant solid, which contained a small amount of residual H2O,
was frozen and lyophilized to dryness. The solid was triturated with
anhydrous Et2O and filtered over a sintered glass funnel. The
resultant solid was washed with copious amounts of anhydrous Et2O
and dried in Vacuo to yield BocHN-(R)-CbzHNγ-ImPyPyPy-CO2Me
9 as a tan solid (518 mg, 96%). 1H NMR: δ 10.17 (s, 1H), 10.00
(s, 1H), 9.95 (s, 1H), 9.93 (s, 1H), 7.46 (d, J ) 1.7 Hz, 1H), 7.44
(s, 1H), 7.31-7.29 (m, 5H), 7.27 (d, J ) 1.7 Hz, 1H), 7.23 (d, J
) 1.7 Hz, 1H), 7.14 (d, J ) 1.7 Hz, 1H), 7.07 (d, J ) 1.7 Hz, 1H),
7.04 (d, J ) 8.3 Hz, 1H), 6.90 (d, J ) 2.0 Hz, 1H), 6.81 (t, J ) 5.9
Hz, 1H), 4.98 (s, 2H), 3.96 (m, 1H), 3.95 (s, 3H), 3.85 (s, 3H),
3.84 (s, 3H), 3.83 (s, 3H), 3.73 (s, 3H), 3.03 (m, 2H), 2.46 (m,
2H), 1.36 (s, 9H). 13C NMR: δ 167.8, 160.8, 158.5, 158.4, 155.84,
155.81, 155.5, 137.1, 136.0, 134.0, 128.3, 127.7, 127.6, 123.06,
123.00, 122.5, 122.2, 121.2, 120.7, 118.7, 118.6, 118.5, 114.0,
108.4, 104.9, 77.8, 65.2, 50.9, 48.8, 43.6, 38.2, 36.20, 36.18, 36.09,
34.9, 28.2. HRMS (FAB+): calcd for C41H49N11O10 [M•]+, 855.3663;
found, 855.3688.
HCl ·H2N-(R)-CbzHNγ-ImPyPyPy-CO2Me (10). A solution of
BocHN-(R)-CbzHNγ-ImPyPyPy-CO2Me 9 (125 g, 0.146 mmol) in
anhydrous HCl in 1,4-dioxane (4.0 M, 10 mL) was stirred at 23
°C for 2 h. The mixture was then diluted with 100 mL of anhydrous
Et2O and filtered over a sintered glass funnel. The resultant solid
was washed with copious amounts of anhydrous Et2O and dried in
Vacuo to yield HCl ·H2N-(R)-CbzHNγ-ImPyPyPy-CO2Me 10 as a
brown solid (114 mg, 99%). 1H NMR: δ 10.38 (s, 1H), 9.98 (s,
1H), 9.96 (s, 1H), 9.94 (s, 1H), 8.10 (m, 3H), 7.46 (d, J ) 1.7 Hz,
1H), 7.45 (s, 1H), 7.42 (d, J ) 8.3 Hz, 1H), 7.34-7.28 (m, 5H),
7.28 (d, J ) 1.7 Hz, 1H), 7.24 (d, J ) 1.7 Hz, 1H), 7.16 (d, J )
1.7 Hz, 1H), 7.08 (d, J ) 1.7 Hz, 1H), 6.90 (d, J ) 1.7 Hz, 1H),
5.02 (m, 2H), 4.14 (m, 1H), 3.95 (s, 3H), 3.85 (s, 3H), 3.84 (s,
3H), 3.83 (s, 3H), 3.73 (s, 3H), 3.02 (m, 2H), 2.63 (m, 2H). 13C
NMR: δ 167.0, 160.8, 158.5, 158.4, 155.7, 136.8, 135.7, 134.0,
128.3, 127.8, 127.7, 123.05, 122.97, 122.5, 122.2, 121.1, 120.7,
118.64, 118.60, 118.5, 108.4, 104.9, 65.6, 50.9, 46.7, 42.0, 38.2,
36.2, 36.1, 36.0, 34.9. HRMS (FAB+): calcd for C36H42N11O8 [M
+ H]+, 756.3218; found, 756.3211.
BocHN-(R)-CbzHNγ-ImPyPyPy-CO2H (11). A solution of Boc-
HN-(R)-CbzHNγ-ImPyPyPy-CO2Me 9 (200 mg, 0.234 mmol) dis-
solved in 1,4-dioxane (2.3 mL) and aqueous NaOH (1 N, 2.3 mL,
2.3 mmol) was stirred at 42 °C for 3 h. The solution was then
added to distilled H2O (5 mL) preacidified with aqueous HCl (1
N, 2.3 mL, 2.3 mmol), yielding a precipitate that was isolated by
centrifugation (∼4500 rpm). The residual solid was again suspended
in distilled H2O (10 mL) and collected by centrifugation (repeated
2×). The resultant solid, which contained a small amount of residual
H2O, was frozen and lyophilized to dryness and then suspended in
excess anhydrous Et2O and filtered, and the filter cake washed with
copious amounts of anhydrous Et2O. Drying of the tan solid in
Vacuo yielded BocHN-(R)-CbzHNγ-ImPyPyPy-CO2H 11 (187 mg,
95%). 1H NMR: δ 12.15 (s, 1H), 10.21 (s, 1H), 10.00 (s, 1H), 9.96
(s, 1H), 9.92 (s, 1H), 7.44 (s, 1H), 7.42 (d, J ) 1.7 Hz, 1H),
7.31-7.29 (m, 5H), 7.28 (d, J ) 1.5 Hz, 1H), 7.24 (d, J ) 1.5 Hz,
1H), 7.16 (d, J ) 1.5 Hz, 1H), 7.08 (m, 2H), 6.85 (d, J ) 1.7 Hz,
1H), 6.82 (t, J ) 5.7 Hz, 1H), 4.98 (s, 2H), 3.95 (m, 4H), 3.85 (s,
3H), 3.84 (s, 3H), 3.81 (s, 3H), 3.03 (m, 2H), 2.46 (m, 2H), 1.36
(s, 9H). 13C NMR: δ 167.8, 162.0, 158.44, 158.38, 155.80, 155.77,
155.4, 137.1, 136.0, 133.9, 128.3, 127.7, 127.6, 123.0, 122.7, 122.6,
122.2, 121.2, 120.2, 119.5, 118.6, 118.5, 114.0, 108.4, 104.87,
104.83, 77.7, 65.1, 48.8, 43.5, 38.2, 36.2, 36.13, 36.06, 34.9, 28.2.
HRMS (FAB+): calcd for C40H47N11O10 [M•]+, 841.3507; found,
841.3498.
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BocHN-(R)-CbzHNγ-ImPyPyPy-(R)-CbzHNγ-ImPyPyPy-
CO2Me (12). A solution of BocHN-(R)-CbzHNγ-ImPyPyPy-CO2H
11 (25 mg, 0.029 mmol) and PyBOP (17 mg, 0.031 mmol) in DMF
(150 µL) and DIEA (16 µL, 0.089 mmol) was stirred at 23 °C for
20 min. The solution was then treated with solid (powdered)
HCl ·H2N-(R)-CbzHNγ-ImPyPyPy-CO2Me 10 (25 mg, 0.031 mmol)
and stirred at 23 °C for 2 h. The solution was then added to distilled
H2O (10 mL) preacidified with aqueous HCl (1 N, 1 mL, 1 mmol),
yielding a precipitate that was isolated by centrifugation (∼4500
rpm). The residual solid was again suspended in distilled H2O (10
mL) and collected by centrifugation (repeated 3×). The resultant
solid, which contained a small amount of residual H2O, was frozen
and lyophilized to dryness. The solid was triturated with anhydrous
Et2O and filtered over a sintered glass funnel. The resultant solid
was washed with copious amounts of anhydrous Et2O and dried in
Vacuo to yield BocHN-(R)-CbzHNγ-ImPyPyPy-(R)-CbzHNγ-ImPy-
PyPy-CO2Me 12 as a tan solid (44 mg, 94%). 1H NMR: δ 10.20
(s, 1H), 10.16 (s, 1H), 9.98 (s, 2H), 9.94-9.91 (m, 4H), 7.99 (m,
1H), 7.46 (d, J ) 1.7 Hz, 1H), 7.45 (s, 1H), 7.44 (s, 1H), 7.32-7.14
(m, 18H), 7.07 (m, 2H), 7.03 (d, J ) 8.3 Hz, 1H), 6.92 (s, 1H),
6.90 (d, J ) 2.0 Hz, 1H), 6.80 (t, J ) 5.6 Hz, 1H), 4.99 (m, 4H),
4.10 (m, 1H), 3.95 (m, 7H), 3.85-3.83 (m, 15H), 3.79 (s, 3H),
3.73 (s, 3H), ∼3.30 (m, 2H, obstructed by H2O peak), 3.04 (m,
2H), 2.53-2.44 (m, 4H, partially obstructed by NMR solvent), 1.36
(s, 9H). 13C NMR: δ 167.9, 167.8, 161.6, 160.8, 158.5, 158.44,
158.42, 155.8, 155.6, 155.5, 137.1, 136.0, 134.00, 133.98, 128.3,
127.7, 127.63, 127.60, 123.11, 123.07, 123.00, 122.80, 122.77,
122.5, 122.3, 122.2, 122.1, 121.3, 120.8, 118.69, 118.66, 118.62,
118.52, 118.0, 114.1, 108.4, 104.9, 104.8, 104.5, 77.8, 65.21, 65.16,
50.9, 48.83, 48.78, 43.6, 42.2, 38.4, 38.2, 36.2, 36.10, 36.07, 36.0,
34.9, 28.2. HRMS (TOF-ESI+): calcd for C76H87N22O17 [M + H]+,
1579.6620; found, 1579.6580.
BocHN-(R)-CbzHNγ-ImPyPyPy-(R)-CbzHNγ-ImPyPyPy-CO2H
(13). A solution of BocHN-(R)-CbzHNγ-ImPyPyPy-(R)-CbzHNγ-
ImPyPyPy-CO2Me 12 (25 mg, 0.0158 mmol) dissolved in 1,4-
dioxane (376 µL) and aqueous NaOH (1 N, 253 µL, 0.253 mmol)
was stirred at 40 °C for 4 h. The solution was then added to distilled
H2O (5 mL) preacidified with aqueous HCl (1 N, 253 µL, 0.253
mmol), yielding a precipitate that was diluted with another 15 mL
of H2O and was then isolated by centrifugation (∼4500 rpm). The
resultant solid, which contained a small amount of residual H2O,
was frozen and lyophilized to dryness and then suspended in excess
anhydrous Et2O, triturated, and filtered, and the filter cake washed
with copious amounts of anhydrous Et2O. Drying of the tan solid
in Vacuo yielded BocHN-(R)-CbzHNγ-ImPyPyPy-(R)-CbzHNγ-ImPy-
PyPy-CO2H 13 (23 mg, 93%). 1H NMR: δ 12.13 (br s, 1H), 10.23
(s, 1H), 10.20 (s, 1H), 9.98-9.90 (m, 6H), 8.01 (m, 1H), 7.443 (s,
1H), 7.439 (s, 1H), 7.42 (d, J ) 1.7 Hz, 1H), 7.30-7.15 (m, 18H),
7.07 (m, 3H), 6.92 (m, 1H), 6.84 (d, J ) 2.0 Hz, 1H), 6.81 (t, J )
5.6 Hz, 1H), 5.00 (m, 2H), 4.98 (s, 2H), 4.10 (m, 1H), 3.95 (m,
7H), 3.85-3.83 (m, 12H), 3.81 (s, 3H), 3.78 (s, 3H), ∼3.30 (m,
2H, obstructed by H2O peak), 3.03 (m, 2H), 2.53 (m, 2H), 2.46
(m, 2H), 1.36 (s, 9H). 13C NMR: δ 167.94, 167.87, 162.4, 162.0,
161.6, 158.54, 158.50, 158.43, 155.8, 155.75, 155.74, 155.6, 155.5,
137.1, 136.0, 133.91, 133.90, 128.3, 127.7, 127.60, 127.57, 123.10,
123.07, 122.8, 122.7, 122.6, 122.3, 122.24, 122.17, 121.16, 121.15,
120.3, 119.5, 118.64, 118.61, 118.5, 118.0, 114.10, 114.06, 108.5,
105.0, 104.5, 77.8, 65.2, 65.1, 48.8, 43.6, 42.2, 38.4, 38.2, 36.2,
36.14, 36.10, 36.08, 36.0, 35.8, 34.9, 28.2. HRMS (TOF-ESI+):
calcd for C75H86N22O17 [M + 2H]2+/2, 783.3271; found, 783.3237.
BocHN-(R)-CbzHNγ-ImPyPyPy-(R)-CbzHNγ-ImPyPyPy-
CO2Pfp (14). A solution of BocHN-(R)-CbzHNγ-ImPyPyPy-
(R)-CbzHNγ-ImPyPyPy-CO2H 13 (250 mg, 0.160 mmol) and DCC
(66 mg, 0.320 mmol) in CH2Cl2 (8.8 mL) was stirred at 23 °C for
45 min. The solution was then treated with DMAP (2 mg, 0.016
mmol) followed by pentafluorophenol (175 mg, 0.950 mmol) and
stirred at 23 °C for 12 h. The reaction mixture was then loaded
onto a silica gel column with CH2Cl2 and eluted with step gradients
of 100% CH2Cl2 to 100% acetone with incremental steps of 5%
acetone. The product was concentrated in Vacuo to yield BocHN-
(R)-CbzHNγ-ImPyPyPy-(R)-CbzHNγ-ImPyPyPy-CO2Pfp 14 as a brown
solid (221 mg, 80%). 1H NMR: δ 10.20 (s, 1H), 10.16 (s, 1H),
10.08 (s, 1H), 9.99-9.91 (m, 5H), 7.99 (m, 1H), 7.73 (d, J ) 1.7
Hz, 1H), 7.444 (s, 1H), 7.440 (s, 1H), 7.30-7.12 (m, 20 H), 7.06
(d, J ) 1.2 Hz, 1H), 7.03 (d, J ) 8.5 Hz, 1H), 6.92 (s, 1H), 6.80
(t, J ) 5.4 Hz, 1H), 5.00 (m, 2H), 4.98 (m, 2H), 4.11 (m, 1H),
3.95 (m, 7H), 3.88 (s, 3H), 3.86-3.84 (m, 12H), 3.78 (s, 3H), ∼3.30
(m, 2H, obstructed by H2O peak), 3.04 (m, 2H), 2.52 (m, 2H), 2.46
(m, 2H), 1.36 (s, 9H). HRMS (TOF-ESI+): calcd for C81H85F5N22O17
[M + 2H]2+/2, 866.3192; found, 866.3236.
cyclo-(-ImPyPyPy-(R)-H2Nγ-ImPyPyPy-(R)-H2Nγ-) (1). A solu-
tion of BocHN-(R)-CbzHNγ-ImPyPyPy-(R)-CbzHNγ-ImPyPyPy-
CO2Pfp 14 (84 mg, 0.049 mmol) in anhydrous CF3CO2H:CH2Cl2
(1:1, 4 mL) was stirred at 23 °C for 10 min prior to being
concentrated to dryness in a 500 mL round-bottom flask. The
residue was then dissolved in cold (0 °C) DMF (10 mL), followed
by immediate dilution with MeCN (300 mL) and DIEA (1.6 mL).
The reaction mixture was left at 23 °C for 3 days without stirring.
[Note: The solution turns cloudy as the macrocycliztion proceeds.]
The reaction mixture was concentrated to a volume of 11 mL and
added to a solution of H2O (30 mL) and aqueous HCl (1 N, 9.2
mL) at 0 °C. The protected intermediate cyclo-(-ImPyPyPy-
(R)-CbzHNγ-ImPyPyPy-(R)-CbzHNγ-) 15 was isolated by centrifuga-
tion (∼4500 rpm), lyophilized to dryness, and then suspended in
excess anhydrous Et2O, triturated, and filtered, and the filter cake
washed with copious amounts of anhydrous Et2O. Drying of the
tan solid in Vacuo yielded the protected intermediate cyclo-
(-ImPyPyPy-(R)-CbzHNγ-ImPyPyPy-(R)-CbzHNγ-) 15. HRMS (TOF-
ESI+): calcd for C70H76N22O14 [M+2H]2+/2, 724.2956; found,
724.2925. This material was immediately deprotected by dissolving
in CF3CO2H (2 mL) followed by addition of CF3SO3H (100 µL) at
23 °C for 5 min. The solution was then frozen, and DMF (2 mL)
was layered over the frozen solution. The thawed solution was
diluted with H2O (6 mL) and purified by reverse-phase HPLC to
give a white solid after lyophilization. The solid was suspended in
excess anhydrous Et2O, triturated, and filtered, and the filter cake
was washed with copious amounts of anhydrous Et2O. Drying of
the white solid in Vacuo yielded cyclo-(-ImPyPyPy-(R)-H2Nγ-
ImPyPyPy-(R)-H2Nγ-) 1 (46 mg, 68%). 1H NMR: δ 10.56 (s, 2H),
9.91 (s, 4H), 9.88 (s, 2H), 8.17 (t, J ) 5.6 Hz, 2H), 7.96 (m, 6H),
7.40 (s, 2H), 7.31 (d, J ) 1.6 Hz, 2H), 7.27 (d, J ) 1.6 Hz, 2H),
7.19 (d, J ) 1.6 Hz, 2H), 7.00 (d, J ) 1.7 Hz, 2H), 6.96 (d, J )
1.6 Hz, 2H), 6.94 (d, J ) 1.7 Hz, 2H), 3.94 (s, 6H), 3.83 (s, 12H),
3.80 (s, 6H), 3.71-3.66 (m, 2H), 3.49-3.27 (m, 4H, partially
obstructed by H2O peak), 2.79 (dd, J ) 16.1 Hz, 6.0 Hz, 2H), 2.60
(dd, J ) 15.2 Hz, 5.2 Hz, 2H). HRMS (TOF-ESI+): calcd for
C54H63N22O10 [M + H]+, 1179.5098; found, 1179.5087.
cyclo-(-ImPyPyPy-(R)-AcHNγ-ImPyPyPy-(R)-H2Nγ-) (3) and
cyclo-(-ImPyPyPy-(R)-AcHNγ-ImPyPyPy-(R)-AcHNγ-) (2). A solu-
tion of cyclo-(-ImPyPyPy-(R)-H2Nγ-ImPyPyPy-(R)-H2Nγ-) 1 (2.81
mg, 2.0 µmol) in anhydrous NMP (200 µL) and DIEA (20 µL) at
23 °C was treated with a solution of Ac2O in NMP (0.122 M, 6.8
µL). After 10 min, the reaction mixture was treated with another
6.8 µL of Ac2O in NMP (0.122 M) and allowed to stand for 5 h.
The reaction mixture was then diluted to a volume of 10 mL by
addition of a 4:1 solution of aqueous CF3CO2H (0.1% v/v):MeCN
(5 mL), followed by additional aqueous CF3CO2H (0.1% v/v, 5
mL), and then purified by reverse-phase HPLC to yield cyclo-
(-ImPyPyPy-(R)-H2Nγ-ImPyPyPy-(R)-H2Nγ-) 1 (363 nmol, 18%),
cyclo-(-ImPyPyPy-(R)-AcHNγ-ImPyPyPy-(R)-H2Nγ-) 3 (800 nmol,
40%), and cyclo-(-ImPyPyPy-(R)-AcHNγ-ImPyPyPy-(R)-AcHNγ-)
2 (432 nmol, 22%). For cyclo-(-ImPyPyPy-(R)-AcHNγ-ImPyPyPy-
(R)-H2Nγ-) 3, HRMS (TOF-ESI+): calcd for C56H65N22O11 [M +
H]+, 1221.5203; found, 1221.5204. For cyclo-(-ImPyPyPy-
(R)-AcHNγ-ImPyPyPy-(R)-AcHNγ-) 2, HRMS (TOF-ESI+): calcd
for C58H68N22O12 [M + 2H]2+/2, 633.2646; found, 633.2631.
ImPyPyPy-(R)-H2Nγ-ImPyPyPy-(+)-IPA (4). Prepared as de-
scribed in the preceding paper.11
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ImPyPyPy-(R)-AcHNγ-ImPyPyPy-(+)-IPA (5). A solution of
polyamide 411 (7.4 mg, 5.03 µmol, assumes 4 as the mono-
CF3CO2H salt) in DMF (1.76 mL) was treated with a solution of
Ac2O in pyridine (10% v/v, 240 µL, 0.254 mmol of Ac2O). The
solution was allowed to stand at 23 °C for 30 min and then acidified
with aqueous CF3CO2H (15% v/v, 2 mL). After 5 min the solution
was further diluted with distilled H2O (5 mL), purified by
preparative RP-HPLC, and lyophilized to dryness. Suspension of
the residual solid in anhydrous Et2O, following by filtration and
drying under high vacuum, yielded 5 (6.7 mg, 95%). HRMS
(FAB+): calcd for C67H79N22O13 [M + H]+, 1399.6191; found,
1399.6181.
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